The goal was to terminate atrial fibrillation (AF) by targeting atrioventricular differences in ionic properties.
ical models were used to interpret experimental findings. The I Kur block did not terminate AF in a majority of experiments (6/9 with 4-AP and 3/4 with DPO-1). AF terminated in mild hyperkalaemia ( not terminate a simulated rotor in cholinergic AF because its contribution to repolarization was dwarfed by the large magnitude of the acetylcholine-activated K + current (I K,ACh ). Simulations showed that the lower availability of the atrial Na + current at depolarized potentials, and a smaller atrial tissue size compared with the ventricle, could partly explain the earlier termination of AF compared with VF during hyperkalaemia.
Conclusion
I Kur is an ineffective anti-arrhythmic drug target in cholinergic AF. Manipulating Na + current 'availability' might represent a viable anti-arrhythmic strategy in AF.
-
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Introduction
Atrial fibrillation (AF) is the most common sustained arrhythmia and enhances the risk of stroke and heart failure. 1 Although nonpharmacological options such as ablation and surgery are increasingly used, anti-arrhythmic drugs constitute the main treatment option. 1 However, their effectiveness has been unsatisfactory and, in some cases, harmful due to side effects. 2 An additional problem that is associated with drugs is that in some cases they precipitate fatal ventricular arrhythmias. 2 As a result, extensive research has been directed towards finding drug targets that are exclusively present in the atria and not in the ventricles. 3 It is now clear that distinct differences exist between the atria and the ventricles in terms of ion channel currents and their underlying transcripts in many species including humans. 4 A K + current that is important in human atrial repolarization, but absent in the ventricle, i.e. the ultra-rapid delayed rectifier current, I Kur , is currently a target for the development of newer anti-arrhythmic drugs to treat AF. 2, 3 However, the results thus far have been highly controversial, with studies suggesting that blockade of I Kur can either be useful in terminating AF 5 or actually be pro-arrhythmic. 6 Furthermore, recent studies have also identified important differences between the biophysical characteristics of the Na + channel (I Na ) between the atria and ventricles, with the atrium displaying more negative steady-state half inactivation membrane voltage properties. 7 This study has opened up another interesting avenue for exploiting atrio-ventricular differences and targeting AF. 8 Our objective was to study acute, carbachol-induced AF in isolated pig hearts and to probe for the usefulness of both the abovementioned ion-channel-based anti-arrhythmic approaches. In experiments, we studied the effectiveness of I Kur block in AF via selective blockers of this current: 4-aminopyridine (4-AP) and DPO-1. We also postulated that the inherent differences in atrio-ventricular Na + channel steady-state inactivation properties could be exploited by manipulating the concentration of extracellular K
We hypothesized that for mild increases in [
the atrial I Na would be more depressed than its ventricular counterpart as a result of its more negative half-inactivation value, resulting in the termination of acute AF, but not ventricular fibrillation (VF). To interpret our experimental results, we also utilized concomitant computer simulations. We reformulated the equations for I Kur that now take into account its rate-dependent attenuation in magnitude. 9 -11 The updated ionic model of an atrial cell 12 was incorporated in a two-dimensional sheet to simulate spiral waves that underlie functional re-entry (rotors) and to study the ionic mechanisms as in a previous study. 13 Our results indicate that I Kur is not a viable anti-arrhythmic target for stopping acute, cholinergic, high-frequency AF in pigs. In contrast, mild hyperkalaemia effectively terminates AF, but not VF in this model.
Methods
Experiments
This investigation conformed to US NIH Guidelines for the Care and Use of Laboratory Animals (NIH publication no. 85-23, revised 1996) . Male pigs (20 -25 kg) were anaesthetized initially by a combination of xylazine (2.2 mg/kg) and telazol (6 mg/kg), followed by thiopental (10 mg/kg) or propofol (6 mg/kg). Hearts were excised and Langendorff-perfused with Tyrode's solution whose composition in millimolar was: NaCl, 130; KCl, 4.0; MgCl 2 , 1; CaCl 2 , 1.8; NaHCO 3 , 24; NaH 2 PO 4 , 1.2; glucose, 5.6; and albumin 0.04 g/L. Tyrode's solution was gassed with 95% O 2 -5% CO 2 , filtered using a Liliput hollow fibre oxygenator (COBE Cardiovascular, Arvada, CO, USA), and perfused at a constant flow rate of 150 -200 mL/min at 36 + 1.08C. After an initial perfusion period of 15 min, blebbistatin (5 -10 mM) was added to the perfusate to abolish motion of the heart. AF was then induced via electrical burst pacing (50 -100 ms cycle length and 10 s duration) or a battery in the presence of carbachol (0.25 -0.5 mM) with 100% success, and the frequency of excitation was mapped for 10 or 20 min (control), before adding 4-AP (100 mM) to selectively block I Kur (for another 10 min). The perfusate containing the carbachol and/or 4-AP was never re-cycled. Movies of di-4-ANNEPS (10 mM) fluorescence during AF were obtained from the left atrium (LA) and the right atrium (RA) using a Little Joe CCD camera (Scimeasure; 80 by 80 pixels, 500 -1000 frames/s, area of field of view 3 cm 2 ). Additionally, two electrograms were simultaneously recorded in the LA and RA to ascertain the presence of either a normal sinus rhythm or AF. Dominant frequency (DF) maps during AF (in control in the presence of carbachol or carbachol + 4-AP) were constructed as in previous studies, 14 and the maximum DF (DF max ) was quantified as a function of time. The DF analysis allows for the quantification of how fast the functional re-entrant activity is at each point on the heart surface in the time domain during fibrillation, and DF max measures the fastest fibrillatory activity. In an additional series of experiments, we investigated the effect of another selective blocker of I Kur , DPO-1. 15 We first studied the effect of DPO-1 on the atrial and ventricular action potential durations (APDs) during pacing and also its effect on carbachol-induced AF and VF dynamics. A second set of experiments studying the effect of hyperkalaemia (6 
Simulations
To investigate the effects of blocking I Kur and changing [K + ] o on re-entry dynamics, we used a modified human atrial cell ionic model 12 incorporated in a two-dimensional sheet to simulate a rotor, as in a previous study. 13 Research in the last two decades has firmly established that transient or stable spiral waves, also called rotors, sustain cardiac fibrillation and represent a useful way to study the underlying ionic properties. 16 The specific model modifications and simulations are discussed in detail in the next section.
3. Results
Experimental
We induced acute AF in nine hearts in the presence of carbachol. We recorded the activation frequencies for 10 min under control conditions, before perfusing 100 mM 4-AP for another 10 min (in three hearts, we ascertained that AF was sustained continuously and thus stable for 20 min, i.e. for the duration of most of our 4-AP experiments). Figure 1A depicts a representative DF map during acute AF in the pig heart. Similar to previous studies in sheep, 17 we found that the DF max was larger in the LA compared with the RA; this was the case in the majority of the DF maps constructed ( 80%). The 1 s single-pixel recordings from the LA and RA shown below the maps also demonstrate faster activation of the electrical excitation in the LA. The variation of DF max with time under control conditions, and in the presence of the drug, 100 mM 4-AP, is shown in Figure 1B for six experiments (each set of symbols represents one experiment) in which AF did not terminate. Statistical analyses of all the movies in these six hearts showed that there was a very small but significant increase in the DF max after the addition of the drug compared with control frequencies (control: 20.97 + 0.26 Hz, n ¼ 79, N ¼ 6; drug 4-AP: 21.98 + 0.35 Hz, n ¼ 65, N ¼ 6; P , 0.05). In the remaining three experiments, AF did terminate in two of three after the addition of 4-AP; however, in one experiment, sustained AF could be re-induced even in the presence of 4-AP.
We also tested the effect of DPO-1 on pig cardiac electrophysiology. First, the effect of DPO-1 on APDs at 50 and 75% repolarization (APD 50 and APD 75 ) was measured at a pacing cycle length of 300 ms (in the absence of carbachol). Representative atrial ( Figure 2E ) and VF ( Figure 2F) ; AF was not terminated in 3/4 experiments, whereas VF did not terminate in 4/4 experiments. In the three experiments in which AF did not terminate, DPO-1 (0.5 mM) decreased the DF max slightly but significantly (control: 23.06 + 0.72 Hz, n ¼ 62, N ¼ 3; drug DPO-1: 20.61 + 0.69 Hz, n ¼ 32, N ¼ 3; P , 0.05). There was no difference in VF frequencies (control: 14.11 + 0.22 Hz, n ¼ 40; drug DPO-1: 13.68 + 0.12 Hz, n ¼ 81; N ¼ 4; P ¼ NS). In additional experiments, we subjected hearts in AF/VF to higher concentrations of DPO-1, i.e. 1.0 and 5.0 mM ( Figure 2G and H ) . At the highest concentration of DPO-1 (5.0 mM), AF terminated in 4/4 experiments, whereas VF did not. Our analyses show no effect of DPO-1 on atrial conduction velocities at all concentrations (data not shown).Therefore, these results suggest that at higher concentrations, DPO-1 also blocks the acteylcholine-dependent K + channel, I K,ACh (activated by carbachol).
In a second series of experiments, hearts in AF were subjected to mild hyperkalaemic conditions, with [K + ] o values increased to either 6 or 8 mM, compared with 4 mM (controls). In four of five experiments, AF terminated spontaneously, and in two experiments, AF converted to an atrial tachycardia before termination (data not shown).
To study the effect of hyperkalaemia on cardiac fibrillation more systematically, in our last series of experiments, both AF and VF were induced and mapped simultaneously. Figure 3B . 
Numerical
For simulations, I Kur inactivation in the human atrial model 16 was re-formulated to include a weighted inactivation of fast and slow gating variables as follows:
where G Kur (ns/pF) is the maximal channel conductivity; u a , u if , and u is the activation and fast and slow inactivation gating variables, respectively; a and b the weighting coefficients; V (mV) the transmembrane voltage; and E K the potassium reversal potential. Classification of inactivation into fast and slow components was performed to reproduce the bi-exponential recovery of I Kur that was observed in porcine atrial cells. 15 The following set of equations and parameters was used for the calculation of Eq. (1): 
and (a, b) = (0.25, 0.75). Figure 4A shows the fast and slow inactivation rate constants as a function of voltage. The dashed line represents the calculated values as per Eq. (2), and the filled circles show experimental data. 13 The Atrial selective ion channels for abolishing AF rate dependence of the normalized I Kur is shown in Figure 4B , using a pacing protocol adapted from Feng et al. 9 (their Figure 5) . We employed 50 ms long pacing pulses rather than the 100 or 200 ms pulses that were originally used to account for the shorter APD in swine atrial myocytes compared with human cells. 11 by a calcium-activated I to2 that was observed in pigs. 10 The resulting characteristic action potential of the adapted ionic kinetics model is shown in Figure 4C for steady-state 1 Hz pacing in normal (continuous) and blocked I Kur (dotted) conditions, exhibiting resemblance to measured swine action potentials in cellular experiments.
11
A simulated re-entry was initiated via cross-field stimulation, in which two appropriately timed line stimuli (S1 and S2) were given from adjacent edges of a two-dimensional sheet, such that S2 was perpendicular to S1, and the coupling interval between the two stimuli allowed for the interaction between the wave front of S2 and the recovering tail of S1 to generate a rotor. 13 The simulations were run for 5 s The leftmost panels in Figure 5A show a snapshot of a rotor (at a particular time) in terms of the absolute membrane voltage in controls and when I Kur was blocked. The DF maps for these rotors are shown in the two right panels of Figure 5A ; the rotor frequencies were similar in both conditions (19.5 Hz) . To understand whether the I Kur blockade had no effect on rotational frequency due to its slow recovery kinetics, we performed an additional numerical experiment, in which I Kur fast and slow inactivation time constants (t uif and t uis ) were made very similar; however, this also did not affect the rotor frequency when I Kur was blocked during carbachol-induced AF (data not shown). We then compared the magnitude of I Kur during re-entry with the largest active K + conductance,
i.e. I K,ACh . Figure 5B shows the distribution of I Kur (left panel) and I K,ACh (right panel) underlying the rotor. I K,ACh is approximately seven times larger in magnitude than I Kur in the rotors. These simulations suggest that I K,ACh masks any effect of I Kur changes and thus have minimal effect on rotor frequency in carbachol-induced AF. However, to test whether the I Kur block is effective in terminating re-entry initiated in the absence of an active I K,ACh , we conducted additional simulations of re-entry in a 4×4 cm tissue ( Figure 5C ). A stable re-entry (with a large core size of 2 × 2 cm) and a DF ¼ 4.4 Hz were observed (top two left panels; Figure 5C ). At 2.5 s post-stimulation, I Kur was blocked, resulting in the annihilation of the rotor at the boundary at 3177 ms (i.e. after 677 ms). Two snapshots of rotors during I Kur block (at t ¼ 3117 ms) and annihilation (at t ¼ 3177 ms) are shown (bottom two left panels; Figure 5C ). The right panel depicts the spiral wave trajectory before and after I Kur block ( Figure 5C , right panel). Thus, in the absence of I K,ACh , at a re-entry frequency of 5 Hz, the block of I Kur terminates re-entry. We conducted additional simulations to study re-entry dynamics during hyperkalaemia. We hypothesized that increased levels of [K + ] o may terminate re-entry activity via reduced sodium availability. 14 The left panel in Figure 6A shows the voltage dependence of the steady-state sodium inactivation (i.e. the product of h and j gates). We incorporated a left-shifted inactivation curve in the atrium compared with the ventricle, as was shown experimentally in dogs. 7 (Data are currently unavailable pertaining to I Na differences between pig atrial and ventricular cells.) As [K + ] o increases, the resting membrane potential will be depolarized according to the Nernst equation. Due to the differences in inactivation curves between the atrium and the ventricle, the availability of sodium channels (hj) will therefore be significantly decreased in the atrium as [K + ] o increases, compared with the ventricle, as shown in Figure 6A , right panel. In Figure 6B , we simulated the effects of hyperkalaemia on AF re-entry in a 3 × 3 cm 2 atrial tissue model.
We investigated the consequences of increasing [K + ] o from 5 to 5.5, 6.0, and 6.2 mM every 1000 ms on rotor stability (four snapshots in Figure 6B , left panels). We noticed that as [K + ] o was increased, the meandering of the spiral wave became more significant, increasing the core size. When [K + ] o reached a level of 6.2 mM, the spiral wave drifted rapidly to the boundary and annihilated. This process is demonstrated by the time-space plot of the spiral tip location that is given in the right panel of Figure 6B . For reference, we repeated these simulations with the sodium inactivation curve relevant to ventricular tissue, for both the same tissue size of 3 × 3 cm 2 ( Figure 6C , upper panels) and an enlarged tissue of 5 × 5 cm 2 ( Figure 6C , lower panels). In both simulations, the tissue sustained spiral wave activity up to much higher [K + ] o levels than those with the left-shifted sodium inactivation curve of the atrium. In the 3 × 3 and 5 × 5 cm 2 tissue models, simulated re-entrant activity was terminated when [K + ] o was higher than 11.0 and 11.2 mM, respectively, by the rotor drifting onto the boundary.
Discussion
The main new findings from this study are as follows. 4.1 Is I Kur an effective anti-arrhythmic target in atrial fibrillation?
I Kur is an attractive target for anti-arrhythmic drug development primarily due to its presence in the atrium and not in the ventricle in humans. 2, 3 However, some doubts exist regarding the efficacy of blocking I Kur to terminate AF due to its frequency-dependent reduction in magnitude. 9 -11 Furthermore, I Kur may be reduced under chronic AF conditions in humans. 13 Despite this, in a chronic AF model in goats, AVE0118, a relatively selective blocker of I Kur , was successful in cardioverting AF. 5 The I Kur block also terminated re-entry under simulated chronic AF conditions. 13 In contrast, in a canine model of cholinergic AF, blocking I Kur with 4-AP did not terminate AF. 6 Instead, I Kur blockade was pro-arrhythmic. 6 Our experimental results in pigs are consistent with this study. 6 Furthermore, our simulation results mimic the experimental findings. Therefore, our working hypothesis is that, at least in acute or paroxysmal models of AF, at frequencies .10 Hz, I Kur is unlikely to be a useful drug target. However, our current ( Figure 5C ) and previous simulation results 13 VF. This potentially relates to the differences in the biophysical properties of I Na availability between the atrium and the ventricle 7 and also partially explains the well-known, but poorly understood, sensitivity of the atrium to hyperkalaemia. 21 An interesting aspect to note in this regard is that at 8 mM [K + ] o where AF seems to terminate, the normal ventricular excitability is expected to be increased, from the well-known biphasic changes in conduction velocity and excitability as a function of [K + ] o . 22 This has been attributed to the decreased difference between the resting membrane potential and the threshold membrane potential. 18 Previous in vivo experiments in dogs showed that both atrial and ventricular tissues demonstrated the biphasic response. 21 However, the threshold value for [K + ] o at which the intra-ventricular conduction time started to reduce with respect to its own controls was much higher (9.3 mM) than a similar threshold for intra-atrial conduction times (7.5 mM). Simultaneous ECG recordings in that study suggested that the QRS and P wave durations mirrored the changes in the intra-ventricular and intra-atrial conduction times, respectively. 21 Thus it is possible to envision a scenario that in a heart with normal ventricular function, small increases in
may not be pro-arrhythmic and thus be safe for terminating AF. However, whether this will also apply in cases of abnormal ventricular function in hearts with an infarct or even pump failure remains unknown. The use of hyperkalaemia to terminate AF in our experiments demonstrates a 'proof-of-principle' experiment that exploits the inherent differences in the Na + channel availability between the atria and the ventricles to attempt and terminate AF. It raises the intriguing question as to whether it might be possible to design a drug that acts by depolarizing the membrane potential or affects I Na channel availability for facilitating the termination of AF, but without compromising safety in the ventricle (i.e. being pro-arrhythmic).
Limitations
In our Langendorff-perfused experiments, we have used the motion uncoupler Blebbistatin; the use of this drug may adversely affect ion channels in the atrium. In our experiments, the heart was not superfused with Tyrode's solution. This will inscribe some temperature gradients across the surface of the heart. Our results suggest that DPO-1 in addition to blocking I Kur at lower concentrations (0.5 mM) may also block I K,ACh (.1mM). Additional patch-clamp experiments will be necessary to systematically determine the I K,ACh blocking properties of DPO-1, including its EC 50 . We have not yet directly investigated the ionic and molecular differences in I Na between the atrium and the ventricle in the pig, including the steady-state inactivation properties in isolated cells. In our computer simulations, we have only used a modified human atrial model (not a detailed pig atrial or ventricular ionic model) and also studied the dynamics of a single rotor, without considering the multiple wavelet theory, or the complex three-dimensional structure of the atria. 1 Additionally, to mimic differences between AF and VF seen experimentally, we have only changed the properties of the Na + current and tissue size. Clearly, many other differences in ion channels, including the inward rectifier K + current, I K1 , exist between the atrium and the ventricle 23 and will need to be more accurately modelled to quantitatively reproduce experimental data.
